261 related articles for article (PubMed ID: 31322768)
1. Value of in vivo α-synuclein deposits in Parkinson's disease: A systematic review and meta-analysis.
Tsukita K; Sakamaki-Tsukita H; Tanaka K; Suenaga T; Takahashi R
Mov Disord; 2019 Oct; 34(10):1452-1463. PubMed ID: 31322768
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein in salivary gland as biomarker for Parkinson's disease.
Campo F; Carletti R; Fusconi M; Pellicano C; Pontieri FE; Di Gioia CR; de Vincentiis M
Rev Neurosci; 2019 Jul; 30(5):455-462. PubMed ID: 30471223
[TBL] [Abstract][Full Text] [Related]
3. Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature.
Schneider SA; Boettner M; Alexoudi A; Zorenkov D; Deuschl G; Wedel T
Eur J Neurol; 2016 Feb; 23(2):247-61. PubMed ID: 26100920
[TBL] [Abstract][Full Text] [Related]
4. Alpha-Synuclein in Peripheral Tissues in Parkinson's Disease.
Ma LY; Liu GL; Wang DX; Zhang MM; Kou WY; Feng T
ACS Chem Neurosci; 2019 Feb; 10(2):812-823. PubMed ID: 30714719
[TBL] [Abstract][Full Text] [Related]
5. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of gut α-synuclein in Parkinson's disease: A systematic review and meta-analysis.
Bu J; Liu J; Liu K; Wang Z
Behav Brain Res; 2019 May; 364():340-347. PubMed ID: 30802532
[TBL] [Abstract][Full Text] [Related]
7. α-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson's disease patients.
Manne S; Kondru N; Jin H; Anantharam V; Huang X; Kanthasamy A; Kanthasamy AG
Mov Disord; 2020 Feb; 35(2):268-278. PubMed ID: 31758740
[TBL] [Abstract][Full Text] [Related]
8. In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease.
Chahine LM; Beach TG; Brumm MC; Adler CH; Coffey CS; Mosovsky S; Caspell-Garcia C; Serrano GE; Munoz DG; White CL; Crary JF; Jennings D; Taylor P; Foroud T; Arnedo V; Kopil CM; Riley L; Dave KD; Mollenhauer B;
Neurology; 2020 Sep; 95(9):e1267-e1284. PubMed ID: 32747521
[TBL] [Abstract][Full Text] [Related]
9. Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review.
Malek N; Swallow D; Grosset KA; Anichtchik O; Spillantini M; Grosset DG
Acta Neurol Scand; 2014 Aug; 130(2):59-72. PubMed ID: 24702516
[TBL] [Abstract][Full Text] [Related]
10. Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
Vilas D; Iranzo A; Tolosa E; Aldecoa I; Berenguer J; Vilaseca I; Martí C; Serradell M; Lomeña F; Alós L; Gaig C; Santamaria J; Gelpi E
Lancet Neurol; 2016 Jun; 15(7):708-718. PubMed ID: 27039162
[TBL] [Abstract][Full Text] [Related]
11. Parkinson disease: Peripheral α-synuclein deposits - prodromal markers for Parkinson disease?
Wood H
Nat Rev Neurol; 2016 May; 12(5):249. PubMed ID: 27080519
[No Abstract] [Full Text] [Related]
12. Submandibular gland is a suitable site for alpha synuclein pathology in Parkinson disease.
Shin J; Park SH; Shin C; Kim JH; Yun TJ; Kim HJ; Jeon B
Parkinsonism Relat Disord; 2019 Jan; 58():35-39. PubMed ID: 30340912
[TBL] [Abstract][Full Text] [Related]
13. Nitrated alpha-synuclein in minor salivary gland biopsies in Parkinson's disease.
Ma LY; Gao LY; Li X; Ma HZ; Feng T
Neurosci Lett; 2019 Jun; 704():45-49. PubMed ID: 30946930
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of minor salivary gland biopsy in clinically diagnosed patients with Parkinson's disease: comparison with DAT PET scans.
Gao L; Chen H; Li X; Li F; Ou-Yang Q; Feng T
Neurol Sci; 2015 Sep; 36(9):1575-80. PubMed ID: 25820147
[TBL] [Abstract][Full Text] [Related]
15. Gut-brain axis and the spread of α-synuclein pathology: Vagal highway or dead end?
Breen DP; Halliday GM; Lang AE
Mov Disord; 2019 Mar; 34(3):307-316. PubMed ID: 30653258
[TBL] [Abstract][Full Text] [Related]
16. Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease.
Fricova D; Harsanyiova J; Kralova Trancikova A
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212934
[TBL] [Abstract][Full Text] [Related]
17. The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease.
Lee JM; Derkinderen P; Kordower JH; Freeman R; Munoz DG; Kremer T; Zago W; Hutten SJ; Adler CH; Serrano GE; Beach TG
J Neuropathol Exp Neurol; 2017 Jan; 76(1):2-15. PubMed ID: 28069931
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease.
Hilton D; Stephens M; Kirk L; Edwards P; Potter R; Zajicek J; Broughton E; Hagan H; Carroll C
Acta Neuropathol; 2014 Feb; 127(2):235-41. PubMed ID: 24240814
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal nervous system α-synuclein as a potential biomarker of Parkinson disease.
Yan F; Chen Y; Li M; Wang Y; Zhang W; Chen X; Ye Q
Medicine (Baltimore); 2018 Jul; 97(28):e11337. PubMed ID: 29995769
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis.
Eusebi P; Giannandrea D; Biscetti L; Abraha I; Chiasserini D; Orso M; Calabresi P; Parnetti L
Mov Disord; 2017 Oct; 32(10):1389-1400. PubMed ID: 28880418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
